Denali Therapeutics, Inc. (DNLI)
18.40
-0.55
(-2.90%)
USD |
NASDAQ |
Oct 13, 16:00
18.34
-0.06
(-0.33%)
After-Hours: 20:00
Denali Therapeutics EPS Diluted (TTM) : -2.838 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.838 |
| March 31, 2026 | -2.881 |
| December 31, 2025 | -2.969 |
| September 30, 2025 | -2.911 |
| June 30, 2025 | -2.808 |
| March 31, 2025 | -2.670 |
| December 31, 2024 | -2.575 |
| September 30, 2024 | -2.765 |
| June 30, 2024 | -2.854 |
| March 31, 2024 | -0.9662 |
| December 31, 2023 | -1.089 |
| September 30, 2023 | -0.9673 |
| June 30, 2023 | -1.082 |
| March 31, 2023 | -2.861 |
| December 31, 2022 | -2.589 |
| September 30, 2022 | -2.462 |
| June 30, 2022 | -2.320 |
| March 31, 2022 | -2.344 |
| December 31, 2021 | -2.392 |
| September 30, 2021 | 0.133 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.2861 |
| March 31, 2021 | 0.2291 |
| December 31, 2020 | 0.2543 |
| September 30, 2020 | -2.217 |
| June 30, 2020 | -2.158 |
| March 31, 2020 | -2.21 |
| December 31, 2019 | -2.066 |
| September 30, 2019 | -0.7108 |
| June 30, 2019 | -0.6058 |
| March 31, 2019 | -0.5849 |
| December 31, 2018 | -0.4388 |
| September 30, 2018 | -1.972 |
| June 30, 2018 | -1.837 |
| March 31, 2018 | -1.493 |
| December 31, 2017 | 0.5792 |
| September 30, 2017 | 1.104 |
| June 30, 2017 | 1.007 |
| March 31, 2017 | 1.253 |
| December 31, 2016 | -0.5548 |
| September 30, 2016 | -0.3399 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Sarepta Therapeutics, Inc. | -2.898 |
| Anixa Biosciences, Inc. | -0.3099 |